This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Central nervous system, other parts/unspecified
CD2_BENIGN_CNS_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum alterius partis specificatae systematis nervosi centralis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Central nervous system, other parts/unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Central nervous system, other parts/unspecified
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 127 | 63 | 64 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | 50.87 | 50.19 | 51.55 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 117
- Matched controls
- 1169
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
110.6
88
*
2259X
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Nervous system, part unspecified
+∞
18.2
17
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
44.7
15.9
19
5
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
9.6
13.4
28
37
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
66.1
10.8
12
*
22599
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Unspecified site
+∞
10.6
10
*
H02AB02
ATC
dexamethasone; systemic
40.0
9.2
11
*
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
8.4
8
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
24.0
8.2
11
5
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
13.1
7.8
13
11
D33.30
ICD-10 Finland
Acoustic neuroma
+∞
7.4
7
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
42.5
6.8
8
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
73.6
6.5
7
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
73.6
6.5
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
6.3
6
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
6.3
6
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
+∞
6.3
6
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
6.3
6
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
6.3
6
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
6.7
6.2
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
16
25
7.18
10.07
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
36
167
2.61
5.17
2.4
2.0
mmol/l
2.4
2.4
0.02
29
141
(3044640) Blood type and Crossmatch panel - Blood
48
257
2.39
5.08
2.8
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
20
68
3.30
4.98
1.2
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
52
299
2.25
4.58
2.4
2.1
mmol/l
2.4
2.3
0.37
43
242
(40768804) Tissue Pathology biopsy report
49
283
2.19
4.21
2.3
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
28
131
2.46
3.88
4.6
6.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
61
393
2.06
3.88
4.9
4.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
12
7.03
3.73
1.9
1.7
nmol/l
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
42
239
2.13
3.67
4.9
4.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
17
63
2.96
3.66
7.9
11.7
%
1.2
1.6
1.00
17
63
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
17
63
2.96
3.66
8.2
11.7
%
0.6
0.7
0.42
17
63
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
36
193
2.21
3.65
2.4
2.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
14
6.02
3.40
1.9
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
24
111
2.43
3.39
6.8
12.8
mmol/l
1.2
1.2
0.03
19
92
(40761535) Cells panel - Urine sediment
20
88
2.51
3.13
3.5
3.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
52
2.90
3.00
1.2
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
65
457
1.87
2.98
8.2
7.1
mmol/l
1.2
1.2
0.09
56
400
(3020891) Body temperature
11
36
3.25
2.88
6.0
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
74
547
1.85
2.85
7.2
6.2
e9/l
4.4
4.3
0.22
66
468
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
20
4.19
2.61
1.5
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
54
371
1.79
2.58
6.5
9.3
inr
1.1
1.3
0.67
14
106
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
5
7
7.37
2.57
3.6
11.1
mg/l
7.7
10.5
—
5
7
(3029937) Albumin [Presence] in Urine by Test strip
41
259
1.86
2.57
5.0
3.8
estimate
0.0
0.0
0.49
11
77
(3000093) Morphology [Interpretation] in Blood Narrative
5
8
6.45
2.39
1.2
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
24
3.49
2.22
1.3
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
14
63
2.37
2.10
3.6
11.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
40
269
1.71
1.98
3.1
3.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
46
322
1.67
1.96
3.5
3.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
41
279
1.69
1.94
3.2
3.1
ph
7.4
7.4
—
7
37
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
33
212
1.75
1.91
1.6
1.7
mg/l
0.9
1.2
0.69
26
168
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
22
3.30
1.91
1.1
2.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
35
2.69
1.84
2.4
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
14
67
2.22
1.84
1.9
1.9
g/l
0.2
0.2
0.16
14
57
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
14
67
2.22
1.84
1.1
1.1
iu/ml
22.2
102.2
—
5
27
(3013115) Eosinophils [#/volume] in Blood
66
513
1.60
1.82
5.7
5.1
e9/l
0.2
0.2
0.55
60
443
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
91
767
1.66
1.77
5.2
3.8
pmol/l
15.0
14.7
0.48
85
691
(3000991) Gas panel - Venous blood
16
83
2.06
1.74
9.1
10.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
64
498
1.57
1.73
5.9
4.9
e9/l
1.8
1.8
0.22
58
436
(3035350) Ketones [Presence] in Urine by Test strip
62
481
1.56
1.69
4.5
3.5
estimate
0.0
0.0
—
10
81
(3021601) Nitrite [Presence] in Urine by Test strip
62
483
1.55
1.65
5.3
4.7
estimate
0.0
0.0
0.00
11
80
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
14
3.67
1.63
1.6
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
89
755
1.60
1.60
4.3
3.9
mm/h
10.7
11.5
0.23
83
687
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
20
3.10
1.60
1.7
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
15
3.42
1.54
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
31
209
1.64
1.49
3.9
4.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
112
1015
1.88
1.48
17.8
11.9
mg/l
22.1
23.0
0.11
93
764
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
52
399
1.51
1.44
3.9
3.4
ng/l
62.2
41.9
0.27
39
276
(3037467) Urinalysis macro (dipstick) panel - Urine
78
653
1.50
1.40
4.5
3.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
17
3.02
1.37
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
61
488
1.48
1.36
4.6
3.5
estimate
0.0
0.0
0.00
11
76
(40758558) Short blood count panel - Blood
32
223
1.58
1.35
6.5
4.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
34
2.44
1.32
1.6
2.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
34
2.44
1.32
1.3
1.4
—
—
—
0
0
(4034850)
8
34
2.44
1.32
10.1
11.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
10
48
2.18
1.31
4.6
2.7
mmol/l
24.8
24.4
—
10
48
(3044290) Cell count panel - Cerebral spinal fluid
5
18
2.85
1.29
1.0
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
157
1.65
1.29
1.4
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
114
1050
1.84
1.26
21.4
14.7
mmol/l
3.9
4.0
1.21
114
1019
(3006315) Basophils [#/volume] in Blood
61
494
1.45
1.25
6.0
4.8
e9/l
0.0
0.0
0.75
56
422
(3018095) Leukocytes [#/volume] in Urine
43
327
1.48
1.21
3.6
3.6
e6/l
20.7
112.1
1.62
38
223
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
38
2.18
1.21
2.6
1.2
—
—
—
0
0
(3013512) EKG study
38
283
1.49
1.18
4.8
3.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
39
2.12
1.17
1.3
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
35
0.00
1.17
0.0
2.3
—
94.3
—
0
23
(3015736) pH of Urine
49
385
1.44
1.16
4.0
3.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
20
2.56
1.16
1.0
2.4
g/l
4.3
4.1
—
5
20
(3004588) Protein electrophoresis panel - Serum or Plasma
11
58
1.98
1.16
3.7
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30
214
1.53
1.14
2.5
1.9
mg/l
2.9
2.9
0.01
25
183
(3019550) Sodium [Moles/volume] in Serum or Plasma
113
1046
1.73
1.11
21.8
14.6
mmol/l
139.6
139.7
0.15
113
1017
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
33
2.18
1.07
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
34
2.12
1.04
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
34
2.12
1.04
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13
77
1.77
0.99
4.2
3.1
—
—
—
0
0
(3009343) pH of Capillary blood
9
50
1.86
0.99
2.1
4.3
—
7.4
—
0
6
(3022313) Gas panel - Capillary blood
7
36
2.00
0.98
2.4
4.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
37
1.94
0.95
2.6
1.2
g/l
2.8
3.1
—
7
28
(3007853) Bacteria identified in Skin by Aerobe culture
18
120
1.58
0.91
1.6
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
31
233
1.44
0.91
4.6
3.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
17
113
1.58
0.87
1.4
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
47
384
1.36
0.85
5.1
3.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
8
46
1.79
0.84
2.8
1.5
ug/l
2.3
8.1
—
8
38
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
115
1.55
0.82
1.5
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
25
185
1.44
0.80
1.9
1.6
nmol/l
1404.8
1203.6
0.52
20
139
(3024928) Oxygen saturation in Venous blood
0
24
0.00
0.80
0.0
3.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
59
1.75
0.78
10.2
8.9
mmol/l
26.8
25.3
—
10
59
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
55
1.68
0.75
1.1
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
39
1.84
0.74
2.6
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
171
1.42
0.72
1.3
1.2
iu/ml
19.2
34.9
—
5
57
(3049717) Cytology report of Urine Cyto stain
5
27
1.89
0.69
4.0
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
43
1.66
0.68
1.0
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
25
319
0.73
0.67
2.5
2.9
u/l
29.8
30.7
0.13
25
302
(3022145) Colonoscopy Study observation
14
95
1.53
0.67
1.3
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
19
138
1.44
0.67
1.3
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
28
1.82
0.67
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
79
712
1.29
0.67
3.9
3.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
29
1.75
0.64
1.4
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
157
1.40
0.64
1.8
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
111
0.61
0.61
1.6
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
20
0.00
0.61
0.0
2.2
—
64.9
—
0
20
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
23
0.00
0.59
0.0
1.6
—
128.5
—
0
14
(3002582) Erythrocytes [#/volume] in Urine
34
279
1.30
0.58
3.6
2.9
e6/l
18.0
69.8
1.25
34
206
(36660697) Celiac disease serology panel - Serum
5
89
0.54
0.58
1.4
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
65
1.41
0.52
2.1
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
99
932
1.28
0.51
6.0
4.5
mu/l
1.8
1.9
0.60
93
837
(3006504) Eosinophils/100 leukocytes in Blood
51
448
1.23
0.50
6.5
5.0
%
2.4
3.1
1.83
46
410
(3026782) Osmolality of Urine
22
174
1.32
0.49
3.6
2.5
mosm/kgh2o
515.8
551.8
0.30
22
141
(3020682) Albumin/Creatinine [Ratio] in Urine
26
313
0.79
0.46
3.2
4.0
mg/mmol
1.4
10.4
3.01
15
201
(1761868) Lipid panel - Serum or Plasma
33
386
0.80
0.45
2.4
2.9
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
7
51
1.39
0.45
5.4
2.1
%
0.9
0.6
—
7
51
(3027008) Opiates [Presence] in Urine
5
31
1.64
0.43
1.2
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
31
1.64
0.43
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
31
1.64
0.43
1.2
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
57
1.43
0.43
2.8
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
32
1.58
0.42
1.2
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
32
1.58
0.42
2.0
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
59
1.38
0.42
1.1
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(4268621)
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
15
0.00
0.41
0.0
1.8
—
15.9
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(4306422)
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
17
0.00
0.41
0.0
1.2
—
1.6
—
0
8
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
34
1.49
0.41
3.0
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.2
—
5.2
—
0
11
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
172
1.26
0.37
2.1
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
90
1.37
0.37
1.5
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
89
937
0.83
0.37
17.1
13.3
%
40.7
40.8
0.10
66
690
(3019832) Treponema pallidum Ab [Presence] in Serum
10
73
1.40
0.35
1.5
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
44
1.38
0.35
4.3
3.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
16
128
1.29
0.34
2.6
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
20
239
0.81
0.33
1.2
1.3
u/ml
0.8
1.6
—
10
63
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
71
662
1.16
0.33
3.4
3.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
54
1.31
0.31
5.4
2.0
%
1.5
1.3
—
7
54
(36304419) Bacteria [Presence] in Urine
29
252
1.20
0.31
3.5
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
56
1.26
0.30
15.0
19.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
28
317
0.85
0.27
2.7
3.0
mmol/l
7.2
8.0
0.44
23
265
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
44
402
1.14
0.26
2.4
1.9
pmol/l
88.0
92.6
0.39
26
210
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
103
996
1.18
0.25
4.0
4.1
mmol/l
1.2
1.3
0.78
94
917
(4010399)
9
75
1.22
0.25
1.3
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
100
965
1.17
0.25
18.4
10.7
ml/min/173m2
81.7
80.4
0.24
89
764
(3018677) aPTT in Platelet poor plasma by Coagulation assay
17
143
1.22
0.25
1.9
1.9
s
29.6
29.7
0.04
17
138
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
44
404
1.14
0.24
2.8
2.4
nmol/l
75.5
76.7
0.16
39
363
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
37
1.37
0.24
1.2
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
10
124
0.79
0.23
1.6
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
113
1104
1.21
0.22
12.2
8.2
u/l
24.0
25.7
0.62
113
1057
(3003338) MCHC [Mass/volume]
93
897
1.14
0.22
22.6
15.3
g/l
332.5
333.1
0.24
93
892
(4027681)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
10
0.00
0.21
0.0
1.8
—
12.0
—
0
10
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
12
0.00
0.21
0.0
1.3
—
90.9
—
0
12
(3044941) Cell count panel - Synovial fluid
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
27
242
1.15
0.20
1.5
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
14
0.00
0.20
0.0
3.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
143
0.82
0.20
1.5
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
157
1.17
0.18
2.2
2.6
e6/l
0.4
1.0
1.53
13
81
(3012516) Albumin [Mass/volume] in Urine
27
297
0.88
0.18
2.7
3.2
mg/l
25.3
278.2
0.63
18
192
(40761536) Microorganisms panel - Urine sediment
8
69
1.17
0.17
5.3
3.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
151
0.85
0.17
2.8
2.9
e6/l
6.5
2.9
—
8
74
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
76
0.78
0.16
1.5
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
108
1058
1.14
0.15
4.7
5.0
mmol/l
2.8
2.7
0.07
100
985
(42870588) Differential panel, method unspecified - Blood
32
297
1.10
0.14
7.0
4.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
105
0.85
0.13
2.4
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
23
210
1.12
0.13
3.3
3.4
ng/l
18.1
121.7
2.00
16
160
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
127
0.85
0.13
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
105
1.16
0.11
1.7
1.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
99
970
1.09
0.11
6.0
5.8
mmol/mol
38.9
39.7
0.38
94
905
(3041096) Erythrocytes [Presence] in Urine by Automated
25
268
0.92
0.10
5.1
3.3
—
—
—
0
0
(1002224) Polysomnography panel
5
47
1.07
0.09
1.6
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
105
1034
1.09
0.09
4.4
4.5
mmol/l
4.7
4.6
0.09
97
964
(3019225) pH of Specimen
9
83
1.09
0.07
9.2
4.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
104
1026
1.08
0.07
4.3
4.5
mmol/l
1.5
1.5
0.01
96
950
(40761511) CBC panel - Blood by Automated count
109
1078
1.08
0.06
16.1
10.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
44
428
1.04
0.04
11.8
7.4
e9/l
0.0
0.0
0.00
37
330
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
111
1.09
0.04
1.5
2.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
115
1142
1.07
0.03
26.7
17.1
fl
90.7
90.9
0.14
115
1122
(3035941) MCH [Entitic mass]
115
1142
1.07
0.03
26.6
17.1
pg
30.3
30.3
0.15
115
1122
(3000963) Hemoglobin [Mass/volume] in Blood
115
1143
1.06
0.01
27.0
17.2
g/l
136.3
137.5
0.39
115
1123
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
106
1.04
0.00
2.3
1.8
—
—
—
0
0
(3000492) Spirometry study
11
106
1.04
0.00
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
206
1.02
0.00
3.0
2.5
ug/l
0.8
0.8
0.08
15
126
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
29
287
1.01
0.00
4.6
3.7
%
21.2
24.4
0.69
17
126
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
57
0.87
0.00
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
2630.0
—
0
5
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
5
0.00
0.00
0.0
3.0
—
67.2
—
0
5
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.0
—
0.7
—
0
6
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
97
0.92
0.00
1.4
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
68
0.88
0.00
1.3
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
6.5
—
0
7
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
26.6
—
0
5
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
59
1.02
0.00
1.3
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
22.7
—
0
6
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
13.9
—
0
5
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
1.0
—
0
6
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
59
0.84
0.00
2.4
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
59
0.84
0.00
1.0
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
9
0.00
0.00
0.0
1.6
—
33.4
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CNS_NOS_EXALLC – Benign neoplasm: Central nervous system, other parts/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).